SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-002218
Filing Date
2021-03-02
Accepted
2021-03-02 07:07:14
Documents
13
Period of Report
2021-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20210302x8k.htm   iXBRL 8-K 33198
2 EX-99.1 tgtx-20210302xex99d1.htm EX-99.1 170615
  Complete submission text file 0001558370-21-002218.txt   337859

Data Files

Seq Description Document Type Size
3 EX-101.SCH tgtx-20210302.xsd EX-101.SCH 2698
4 EX-101.LAB tgtx-20210302_lab.xml EX-101.LAB 16172
5 EX-101.PRE tgtx-20210302_pre.xml EX-101.PRE 11165
6 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210302x8k_htm.xml XML 4781
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 21701269
SIC: 2834 Pharmaceutical Preparations